SEC Form 4 research
| Issuer | Syndax Pharmaceuticals Inc |
|---|---|
| Tickers | SNDX |
| Reporting owners | 54 |
| Officers and directors | 15 |
| Last public filing | 2026-10-30 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-30 | 2026-10-29 | Podlesak Dennis | S | 8,000 | $14.21 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.